Kidnex IV
- Product NDC
- 44911-0747
- 11-digit product format
- 449110747
- Labeler code
- 44911
- Product ID
- 44911-0747_f9c3c3d4-63ce-4b8e-a2b8-8e6acd48b769
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ginkgo Biloba, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Germanium Sesquioxide, Mercurius Vivus, Nux Vomica, Kidney (Suis), Lymph Node (Suis), Naphthochinonum, Natrum Oxalaceticum, Phosphorus, Urinary Bladder (Suis), Aconiticum Acidum, Cis-
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2026-02-26
- Substance
- 1,4-NAPHTHOQUINONE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COPPER; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; MALIC ACID; MERCURY; OXOGLURIC ACID; PHOSPHORUS; PORK KIDNEY; PYRUVIC ACID; SILVER; SODIUM DIETHYL OXALACETATE; STRYCHNOS NUX-VOMICA SEED; SUCCINIC ACID; SUS SCROFA LYMPH; SUS SCROFA URINARY BLADDER
- Active strength
- 12; 30; 8; 12; 8; 12; 6; 12; 8; 12; 8; 12; 12; 8; 12; 12; 12; 8; 12; 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Kidnex IV
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| 1,4-NAPHTHOQUINONE | 12 [hp_X]/mL |
| ACONITIC ACID, (Z)- | 30 [hp_X]/mL |
| ANHYDROUS CITRIC ACID | 8 [hp_X]/mL |
| COPPER | 12 [hp_X]/mL |
| FUMARIC ACID | 8 [hp_X]/mL |
| GERMANIUM SESQUIOXIDE | 12 [hp_X]/mL |
| GINKGO | 6 [hp_X]/mL |
| GOLD | 12 [hp_X]/mL |
| MALIC ACID | 8 [hp_X]/mL |
| MERCURY | 12 [hp_X]/mL |
| OXOGLURIC ACID | 8 [hp_X]/mL |
| PHOSPHORUS | 12 [hp_X]/mL |
| PORK KIDNEY | 12 [hp_X]/mL |
| PYRUVIC ACID | 8 [hp_X]/mL |
| SILVER | 12 [hp_X]/mL |
| SODIUM DIETHYL OXALACETATE | 12 [hp_X]/mL |
| STRYCHNOS NUX-VOMICA SEED | 12 [hp_X]/mL |
| SUCCINIC ACID | 8 [hp_X]/mL |
| SUS SCROFA LYMPH | 12 [hp_X]/mL |
| SUS SCROFA URINARY BLADDER | 12 [hp_X]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBF5ZU7R7K, OF5471ZHRR, XF417D3PSL, 789U1901C5, 88XHZ13131, 96WE91N25T, 19FUJ2C58T, 79Y1949PYO, 817L1N4CKP, FXS1BY2PGL, 8ID597Z82X, 27YLU75U4W, X7BCI5P86H, 8558G7RUTR, 3M4G523W1G, 6CA025Y4FG, 269XH13919, AB6MNQ6J6L, 33A7VYU29L, 3G7U72W8DA |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 44911-0747-1 | Kidnex IV | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | | 1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 44911-0747-1 | 44911074701 | 30 mL in 1 BOTTLE, DROPPER (44911-0747-1) | 30 ml | 2026-02-26 | No | No | Current |